Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Hidetsugu, Fujigaki"'
Autor:
Miho Imaeda, Satoshi Tanaka, Tomoko Oya-Ito, Mariko Uematsu, Hidetsugu Fujigaki, Kuniaki Saito, Masahiko Ando, Norio Ozaki
Publikováno v:
Journal of Eating Disorders, Vol 12, Iss 1, Pp 1-12 (2024)
Abstract Background Secondary carnitine deficiency in patients with anorexia nervosa has been rarely reported. This study aimed to investigate the occurrence of carnitine deficiency in severely malnourished patients with eating disorders during refee
Externí odkaz:
https://doaj.org/article/41a5dda4c2a4451db78773e03d67537a
Autor:
Yuya Ishihara, Hiroyuki Naruse, Hidetsugu Fujigaki, Reiko Murakami, Tatsuya Ando, Kouhei Sakurai, Komei Uehara, Koki Shimomae, Eirin Sakaguchi, Hidekazu Hattori, Masayoshi Sarai, Junnichi Ishii, Ryosuke Fujii, Hiroyasu Ito, Kuniaki Saito, Hideo Izawa
Publikováno v:
Vaccines, Vol 12, Iss 7, p 786 (2024)
Preexisting cardiovascular disease (CVD) is a pivotal risk factor for severe coronavirus disease 2019 (COVID-19). We investigated the longitudinal (over 1 year and 9 months) humoral and cellular responses to primary series and booster doses of mRNA C
Externí odkaz:
https://doaj.org/article/51df4beec8334b4082e3be3b70c927d3
Autor:
Ryosuke Jozuka, Hiroki Kimura, Takashi Uematsu, Hidetsugu Fujigaki, Yasuko Yamamoto, Masato Kobayashi, Kazuya Kawabata, Haruki Koike, Toshiya Inada, Kuniaki Saito, Masahisa Katsuno, Norio Ozaki
Publikováno v:
Neuropsychopharmacology Reports, Vol 42, Iss 1, Pp 114-119 (2022)
Abstract Background Coronavirus disease 2019 (COVID‐19) is known to cause not only respiratory but also neuropsychiatric symptoms, which are assumed to be derived from a cytokine storm and its effects on the central nervous systems. Patients with C
Externí odkaz:
https://doaj.org/article/fb3f33b34975442384d232a755081e43
Autor:
Takenao Koseki, Mayumi Teramachi, Minako Koga, Minoru S. H. Ko, Tomokazu Amano, Hong Yu, Misa Amano, Erica Leyder, Maria Badiola, Priyanka Ray, Jiyoung Kim, Akihiro C. Ko, Achouak Achour, Nan-ping Weng, Takumi Imai, Hisako Yoshida, Satsuki Taniuchi, Ayumi Shintani, Hidetsugu Fujigaki, Masashi Kondo, Yohei Doi
Publikováno v:
Vaccines, Vol 11, Iss 12, p 1767 (2023)
mRNA vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have played a key role in reducing morbidity and mortality from coronavirus disease 2019 (COVID-19). We conducted a double-blind, placebo-controlled phase I/II trial t
Externí odkaz:
https://doaj.org/article/18beafabbfdd4081a2b1ad576923e462
Autor:
Hidetsugu Fujigaki, Yasuko Yamamoto, Takenao Koseki, Sumi Banno, Tatsuya Ando, Hiroyasu Ito, Takashi Fujita, Hiroyuki Naruse, Tadayoshi Hata, Saya Moriyama, Yoshimasa Takahashi, Tadaki Suzuki, Takahiro Murakami, Yukihiro Yoshida, Yo Yagura, Takayoshi Oyamada, Masao Takemura, Masashi Kondo, Mitsunaga Iwata, Kuniaki Saito
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 1 (2022)
ABSTRACT To fight severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), mass vaccination has begun in many countries. To investigate the usefulness of a serological assay to predict vaccine ef
Externí odkaz:
https://doaj.org/article/02f37115e02d48b4a436a03cac1f74b1
Publikováno v:
Fujita Medical Journal, Vol 8, Iss 2, Pp 65-66 (2022)
Externí odkaz:
https://doaj.org/article/8b42032ffc8e473c9e9c57f134117f84
Autor:
Masaki Ishikawa, Yasuko Yamamoto, Bolati Wulaer, Kazuo Kunisawa, Hidetsugu Fujigaki, Tatsuya Ando, Hiroki Kimura, Itaru Kushima, Yuko Arioka, Youta Torii, Akihiro Mouri, Norio Ozaki, Toshitaka Nabeshima, Kuniaki Saito
Publikováno v:
FEBS Journal; Mar2024, Vol. 291 Issue 5, p945-964, 20p
Autor:
Hidetsugu Fujigaki, Masao Takemura, Michiko Osawa, Aki Sakurai, Kentaro Nakamoto, Koichi Seto, Takashi Fujita, Tadayoshi Hata, Hidehiko Akiyama, Yohei Doi, Kuniaki Saito
Publikováno v:
Heliyon, Vol 6, Iss 9, Pp e04929- (2020)
Background: Several immunochromatographic serological test kits have been developed to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific antibodies, but their relative performance and potential clinical utility is unclear.
Externí odkaz:
https://doaj.org/article/a7a484bf5fda4c56970ee11e2aa3bd58
Autor:
Hisayoshi Kubota, Kazuo Kunisawa, Moe Niijima, Mami Hirakawa, Yuko Mori, Masaya Hasegawa, Suwako Fujigaki, Hidetsugu Fujigaki, Yasuko Yamamoto, Kuniaki Saito, Toshitaka Nabeshima, Akihiro Mouri
Publikováno v:
Biochemical and Biophysical Research Communications. 629:142-151
Phencyclidine (PCP) causes mental symptoms that closely resemble schizophrenia through the inhibition of the glutamatergic system. The kynurenine (KYN) pathway (KP) generates metabolites that modulate glutamatergic systems such as kynurenic acid (KA)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86630000e32206e90456300d78853738
https://doi.org/10.1016/j.bbrc.2022.09.003
https://doi.org/10.1016/j.bbrc.2022.09.003
Autor:
Hiroya Menjo, Midori Hasegawa, Hidetsugu Fujigaki, Takuma Ishihara, Shun Minatoguchi, Shigehisa Koide, Hiroki Hayashi, Midori Saito, Kazuo Takahashi, Hiroyasu Ito, Yukio Yuzawa, Kuniaki Saito, Naotake Tsuboi
Publikováno v:
Internal Medicine; 2023, Vol. 62 Issue 23, p3445-3454, 10p